FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paolo Bidoli

Research Profile

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Diego Cortinovis; B Frigeni; P Alberti; Paolo Bidoli; G Cavaletti
Neuroprotectant agents against oxaliplatin induced neurotoxicity: lackings, facts and future prospective.
Marta Scorsetti; Filippo Alongi; Diego Cortinovis; Piera Navarria; Paolo Bidoli
Overall and disease-free survival greater than 12 years in metastatic non-small cell lung cancer after linear accelerator-based stereotactic radiosurgery for solitary brain metastasis.
Diego Cortinovis; Paolo Bidoli; Daniela Cullurà; Vito Lorusso; Antonio Ardizzoia; Vito Amoroso; Mauro Bandera; Enrico Aitini; Alberto Fusi; Nicoletta Zilembo; Daniela Radula; Emilio Bajetta
Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paolo Bidoli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Diego Cortinovis; B Frigeni; P Alberti; Paolo Bidoli; G Cavaletti
Neuroprotectant agents against oxaliplatin induced neurotoxicity: lackings, facts and future prospective.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(5):1418-9.
2012: Marta Scorsetti; Filippo Alongi; Diego Cortinovis; Piera Navarria; Paolo Bidoli
Overall and disease-free survival greater than 12 years in metastatic non-small cell lung cancer after linear accelerator-based stereotactic radiosurgery for solitary brain metastasis.
Tumori 2012;98(2):31e-34e.
2008: Diego Cortinovis; Paolo Bidoli; Daniela Cullurà; Vito Lorusso; Antonio Ardizzoia; Vito Amoroso; Mauro Bandera; Enrico Aitini; Alberto Fusi; Nicoletta Zilembo; Daniela Radula; Emilio Bajetta
Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(4):405-11.
2007: Paolo Bidoli; Nicoletta Zilembo; Diego Cortinovis; Luigi Mariani; Luciano Isa; Enrico Aitini; D Cullurà; Franca Pari; Paola Nova; M Mancin; Barbara Formisano; Emilio Bajetta
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):461-7.
2004: Erminia Ferrario; Leonardo Ferrari; Paolo Bidoli; Daniela De Candis; Michele Del Vecchio; Sara De Dosso; Roberto Buzzoni; Emilio Bajetta
Treatment of cancer-related anemia with epoetin alfa: a review.
Cancer treatment reviews 2004;30(6):563-75.
2004: Nicoletta Zilembo; Emilio Bajetta; Ettore Bichisao; Antonia Martinetti; Ignazia La Torre; Paolo Bidoli; Raffaella Longarini; Tindara Portale; Ettore Seregni; Emilio Bombardieri
The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2004;58(4):255-9.
2004: Paolo Bidoli; Simonetta Chiara Stani; Luigi Mariani; Daniela De Candis; Diego Cortinovis; Stefania Aglione; Nicoletta Zilembo; Luisa Toffolatti; Barbara Formisano; Emilio Bajetta
Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;43(2):203-8.
2003: Antonia Martinetti; Nicoletta Zilembo; Leonardo Ferrari; Giorgio Massimini; Anna Polli; Ignazia La Torre; riccardo giovanazzi; Paola Pozzi; Paolo Bidoli; Daniela De Candis; Ettore Seregni; Emilio Bombardieri; Emilio Bajetta
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate.
Anticancer research 2003;23(4):3485-91.
2003: Daniela De Candis; Simonetta Chiara Stani; Paolo Bidoli; Vittorio Amedeo Bedini; Paolo Potepan; Pierina Navarria; Stefania Aglione; Emilio Bajetta
Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC).
American journal of clinical oncology 2003;26(3):265-9.
2003: Emilio Bajetta; Simonetta Chiara Stani; Daniela De Candis; Nadia Zaffaroni; Nicoletta Zilembo; Diego Cortinovis; Stefania Aglione; Luigi Mariani; Barbara Formisano; Paolo Bidoli
Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):242-7.
2002: Paolo Bidoli; Stefania Aglione; Luisa Toffolatti; Daniela De Candis; Emilio Bajetta
[New strategies in the treatment of esophageal cancer].
Minerva chirurgica 2002;57(6):717-31.
2002: Paolo Bidoli; Emilio Bajetta; Simonetta Chiara Stani; Candis Daniela De; Armando Santoro; Maurizio Valente; Roberto Zucali; Pinuccia Valagussa; Gianni Ravasi; Gianni Bonadonna
Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
Cancer 2002;94(2):352-61.
2001: Paolo Bidoli; Simonetta Chiara Stani; Daniela De Candis; Diego Cortinovis; H S Parra; Emilio Bajetta
Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus.
Tumori 2001;87(5):299-302.
2000: Emilio Bajetta; S Chiara Stani; Daniela De Candis; Paolo Bidoli; Luigi Mariani; Nicoletta Zilembo; Paola Pozzi; Giuseppe Procopio
Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial.
Cancer 2000;89(4):763-8.
2000: Emilio Bajetta; Nicoletta Zilembo; Ettore Bichisao; Antonia Martinetti; Roberto Buzzoni; Paola Pozzi; Paolo Bidoli; Leonardo Ferrari; Luigi Celio
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1017-22.
1998: Federico Bozzetti; Luca Cozzaglio; Cecilia Gavazzi; Paolo Bidoli; Giuliano Bonfanti; F Montalto; H Soto Parra; M Valente; Roberto Zucali
Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival.
Tumori 1998;84(6):681-6.
1997: Raffaella Villa; D Gornati; Nadia Zaffaroni; S Veneroni; Paolo Bidoli; A Severini
Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents.
Anticancer research 1997;17(2A):961-8.